It can be uncomfortable to talk about IBS, but doing so can help you find support and feel less alone. Deciding who to tell and how much to share can help get the conversation started. Irritable bowel ...

Findings showed 30% of patients taking linaclotide 145mcg achieved the primary endpoint of combined responder. The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the ...

Ironwood Pharmaceuticals (NASDAQ:IRWD) executives highlighted stronger demand trends for LINZESS, a revamped pricing approach intended to improve 2026 net sales performance, and key next steps for the ...

With a new corporate sponsorship in hand, Ardelyx is aiming for a hole-in-one in the awareness-raising game. | With a new corporate sponsorship in hand, Ardelyx is aiming for a hole-in-one in the ...

For millions of Americans, bathroom trips bring anxiety rather than relief. Irritable bowel syndrome with constipation (IBS-C) impacts approximately one-third of all IBS cases, causing physical ...

Dear Dr. Roach: I'm a young adult male who has been diagnosed with irritable bowel syndrome with constipation (IBS-C). Until this diagnosis, I had never even heard of the condition. A colonoscopy and ...

A recent survey weighed the needs and experiences of IBS-C patients with the challenges healthcare providers face when treating them. Using an online questionnaire, the researchers surveyed patients ...

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a global GI-focused healthcare company, presented new data from four scientific abstracts during the American College of ...

Please provide your email address to receive an email when new articles are posted on . Compared with placebo, LinZess significantly decreased abdominal symptoms such as bloating, discomfort and pain ...

Ardelyx (ARDX) stock rises as the company partners with the LPGA to boost awareness on irritable bowel syndrome with ...

How do you help patients with soft stool that won't move through manage idiopathic constipation? Join Drs Lin Chang and Anthony Lembo as they discuss nuanced decision-making around treating IBS ...